Mohammed D. Al Shubbar

Dr. Mohammed D. Al Shubbar

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SASafi Alqatari
Safi Alqatari
AQAbdulaziz Al Qunais
Abdulaziz Al Qunais
SAShahad Alali
Shahad Alali
MAMohammed A Alharbi
Mohammed A Alharbi
MHManal Hasan
Manal Hasan
MSMohammed D. Al Shubbar
Mohammed D. Al Shubbar
VEXAS syndrome is a recently identified autoinflammatory disorder resulting from somatic mutations in the UBA1 gene, leading to a complex spectrum of severe inflammatory and hematologic manifestations. The absence of established treatment guidelines and the variability in clinical presentation make its management particularly challenging. Current therapeutic approaches are often based on limited evidence, and their effectiveness remains inconsistent. This review seeks to consolidate the existing knowledge on therapeutic strategies for VEXAS syndrome, offering a critical evaluation of their efficacy and addressing the gaps in the current literature. As the clinical recognition of VEXAS grows, there is an urgent need to explore more targeted, effective treatments that can address both the inflammatory and hematologic aspects of the disease. By providing a comprehensive analysis of the current therapeutic landscape, this review aims to guide clinicians and researchers toward developing more effective, long-term management strategies for this life-threatening condition.

18 July 2025 in Medicina
Verified
Journal Article
Open access
PDF file
SASafi Alqatari
Safi Alqatari
AAAbrar J Alwaheed
Abrar J Alwaheed
MHManal Hasan
Manal Hasan
RAReem Jaafar Al Argan
Reem Jaafar Al Argan
MAMarj M. Alabdullah
Marj M. Alabdullah
MSMohammed D. Al Shubbar
Mohammed D. Al Shubbar
Obesity is a chronic, relapsing disease with multifactorial origins and significant global health implications. Historically, bariatric surgery has been the most effective intervention for achieving sustained weight loss and metabolic improvement, especially in individuals with moderate to severe obesity. However, the therapeutic landscape is rapidly evolving. Recent advances in pharmacotherapy—including GLP-1 receptor agonists, dual and triple incretin agonists, and amylin-based combination therapies—have demonstrated unprecedented efficacy, with some agents inducing 15–25% weight loss, approaching outcomes once exclusive to surgical intervention. These developments challenge the continued applicability of existing bariatric surgery criteria, which were established in an era of limited medical alternatives. In this narrative review, we examine the evolution of surgical eligibility thresholds and critically assess the potential role of novel pharmacotherapies in redefining treatment algorithms. By comparing the efficacy, safety, metabolic benefits, and cost-effectiveness of surgery versus next-generation drugs, we explore whether a more stepwise, pharmacotherapy-first approach may now be justified, particularly in patients with BMI 30–40 kg/m2. We also discuss future directions in obesity management, including personalized treatment strategies, perioperative drug use, and the integration of pharmacologic agents into long-term care pathways. As the field advances, a paradigm shift toward individualized, minimally invasive interventions appears inevitable—necessitating a timely re-evaluation of current bariatric surgery guidelines to reflect the expanding potential of medical therapy.

22 January 2025 in Medicina
Verified
Journal Article
Open access
PDF file
MHManal Hasan
Manal Hasan
MAMaram A. Alismail
Maram A. Alismail
DBDanah Bokhari
Danah Bokhari
RARehab F. Alghamdi
Rehab F. Alghamdi
ZAZainab E. Alhalal
Zainab E. Alhalal
MSMohammed D. Al Shubbar
Mohammed D. Al Shubbar
Background: Systemic lupus erythematosus (SLE) is a complex autoimmune disease that leads to systemic inflammation and damage across various organs, including the respiratory system. The prevalence of pleuropulmonary manifestations in SLE patients, particularly in Saudi Arabia, remains underexplored. Objective: This study aims to determine the frequency of pleuropulmonary involvement in SLE patients at King Fahd Hospital of the University (KFUH), Khobar, Saudi Arabia, and identify factors associated with the presence of such findings. Method: A retrospective analysis was conducted on adult SLE patients at KFUH, using hospital medical records for data collection on demographic characteristics, clinical features, and immunological markers. Pleuropulmonary involvement was defined based on high-resolution computed tomography (HRCT) findings. Statistical analyses evaluated associations between pleuropulmonary findings and clinical or immunological parameters. Results: Out of 207 SLE patients (mean age 39.9 years, 92.8% female), 17.4% showed pleuropulmonary involvement on HRCT, with pleurisy being the most prevalent manifestation, followed by pulmonary nodules. Significant associations were found between pleuropulmonary involvement and positive rheumatoid factor (p = 0.002), cardiac involvement (p = 0.002), and higher SLICC/ACR damage index scores (p = 0.001). Patients with positive rheumatoid factor and elevated SLICC/ACR damage index had increased odds of developing pleuropulmonary complications (3.73- and 7.28-fold, respectively). Conclusions: Pleuropulmonary involvement in SLE patients is associated with clinical and immunological markers, including rheumatoid factor, cardiac involvement, and higher SLICC/ACR damage index scores. Recognizing these associations may improve the early detection and targeted management of high-risk patients.

22 February 2025 in Medicina
Verified
Journal Article
Open access
PDF file
MAMaher Alqurashi
Maher Alqurashi
ASAsma Ali Sawan
Asma Ali Sawan
MBMahmoud Mohamed Berekaa
Mahmoud Mohamed Berekaa
BHBasavaraja C. Hunasemarada
Basavaraja C. Hunasemarada
MSMohammed D. Al Shubbar
Mohammed D. Al Shubbar
Ayman A. El-BadryAyman A. El-Badry
Ayman A. El-Badry
Background and Objectives: Despite extensive research on the sources and transmission pathways of Hospital-Acquired Infections (HAIs), the role of cleaning staff as potential vectors has been under-explored. This study addresses the gap by examining the cleaning staff’s role in nosocomial infection transmission, focusing on pathogenic bacteria and fungi colonization. Identifying potential pathogens harbored by cleaning staff that carry the risk of causing HAIs, especially methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae. Materials and Methods: This current cross-sectional study was conducted on 96 cleaning staff at King Fahad Hospital of the University and Family and Community Medicine-Centre, Eastern Province, Saudi Arabia. Sample collection targeted hands and nostrils using cotton swabs, followed by laboratory testing, including MALDI-TOF mass spectrometry for bacterial identification, and the cefoxitin disc diffusion test for the screening of MRSA. Results: In total, the occurrence of MRSA colonization was 9.4% while Enterobacteriaceae colonization was 15.6%. No significant correlation was found for MRSA among departments or between day and night shifts. Alternatively, individuals working in the ICU and the operating room showed higher chances of being colonized by Enterobacteriaceae, and a notable connection was identified between Enterobacteriaceae and day shifts. Ultimately, the frequency of handwashing reduced the chances of being colonized by MRSA and Enterobacteriaceae, underscoring the significance of good hygiene practices. Conclusions: The study highlights the potential role of cleaning staff in transmitting HAIs, indicating a need for further research and consideration of enhanced hygiene protocols in hospital settings.

21 March 2024 in Cureus
Verified
Journal Article
Open access
PDF file
MSMohammed D. Al Shubbar
Mohammed D. Al Shubbar
This review offers an insight into the historical background, utilization, chemical composition, health impacts, processes, and cultural aspects associated with the usage of khat, a psychoactive, mind-altering plant indigenous to the Arabian Peninsula and the Horn of Africa. It further explores the cultural importance of khat in nations such as Saudi Arabia, Yemen, Ethiopia, and Somalia, detailing its chemical makeup containing alkaloids and other compounds, its physiological impact on the body, and its potential health risks like cardiovascular complications, mental health disorders, and dental problems. The cultural, economic, and religious aspects that affect perceptions and consumption of khat were also considered while emphasizing its usage despite legal bans in many nations.

26 December 2025 in Obesity Medicine
Verified
Journal Article
Closed access
RAReem Jaafar Al Argan
Reem Jaafar Al Argan
SASafi Alqatari
Safi Alqatari
AAAbrar J Alwaheed
Abrar J Alwaheed
MHManal Hasan
Manal Hasan
SAShaya Alqahtani
Shaya Alqahtani
NANoor H. AlYousef
Noor H. AlYousef